drugset
drugset / Trial / NCT03484845

Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy

NCT03484845 ↗

Phase 1/2 Unknown 150 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will conducted to evaluate and comparison between the effectiveness, safety and acceptability of lactoferrin alone, ferrous fumarate alone and combination of both for the treatment of mild to moderate IDA during pregnancy.

Timeline

Start
2018-11-01
Primary completion
2019-12-01
Completion
2019-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 30 mg Oral
Comparator Ferrous Sulfate Diagnostic / imaging agent 60 mg Oral
Comparator Lactoferrin Protein / enzyme biologic 100 mg Oral
Comparator Lactoferrin Protein / enzyme biologic 200 mg Oral

Indications

iron deficiency anemia